TB-500 Research Supplier — Australia
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare exports TB-500 (CAS: 77591-33-4) to research institutions in Australia. Our WHO-GMP certified facility in India supplies 98%+ purity TB-500 for wound healing and actin modulation research.
TB-500 Export Specifications for Australia
| Compound | TB-500 |
| CAS Number | 77591-33-4 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Regulatory Reference | TGA |
| Shipping | DHL/FedEx temperature-controlled |
| Transit to Australia | 5-10 business days |
| Documentation | CoA, HPLC, MS, export docs |
Research Applications of TB-500
TB-500 is used in wound healing and actin modulation research. Research institutions in Australia source this compound for preclinical studies under applicable TGA research regulations.
Why Australia Researchers Source TB-500 from India
- WHO-GMP certified Indian manufacturer — internationally recognised compliance
- Competitive pricing for bulk research quantities
- Full export documentation package for TGA compliance
- Temperature-controlled DHL/FedEx shipping to Australia
- Dedicated international research supply team
- 98%+ purity guaranteed with independent third-party CoA
Related Peptides in Australia
Semaglutide in Australia | Tirzepatide in Australia | Retatrutide in Australia | Liraglutide in Australia
TB-500 — Other Countries
TB-500 in USA | TB-500 in UK | TB-500 in Germany | TB-500 in Canada
Source from India — Key Manufacturing Cities
TB-500 in Mumbai, India | TB-500 in Delhi, India | TB-500 in Hyderabad, India | TB-500 in Bangalore, India
Request TB-500 for your Australia research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.
